首页> 外文OA文献 >A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era

【2h】

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era

机译：Ibrutinib时代慢性淋巴细胞白血病有效免疫疗法的CD19 / CD3双特异性抗体

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hannah R. Robinson; Junpeng Qi; Erika M. Cook; Cydney Nichols; Eman L. Dadashian; Chingiz Underbayev; Sarah E. M. Herman; Nakhle S. Saba; Keyvan Keyvanfar; Clare Sun; Inhye E. Ahn; Sivasubramanian Baskar; Christoph Rader; Adrian Wiestner;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era [J] . Robinson Hannah R., Qi Junpeng, Cook Erika M., Blood: The Journal of the American Society of Hematology . 2018,第5期

机译：Ibrutinib时代慢性淋巴细胞白血病有效免疫治疗的CD19 / CD3双特异性抗体
2. CD19 CAR-T Cells Are Highly Effective in Ibrutinib-Refractory Chronic Lymphocytic Leukemia [J] . Turtle Cameron J., Hanafi Laila-Aicha, Li Daniel, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：CD19 CAR-T细胞在依鲁替尼难治性慢性淋巴细胞白血病中高度有效
3. CD19 CAR-T Cells Are Highly Effective in Ibrutinib-Refractory Chronic Lymphocytic Leukemia [J] . Turtle Cameron J., Hanafi Laila-Aicha, Li Daniel, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：CD19 CAR-T细胞在依鲁替尼难治性慢性淋巴细胞白血病中高度有效
4. A CD19/CD3 Bispecific TandAb, AFM11, Recruits T Cells to Potently and Safely Kill CD19+ Tumor Cells in Pre-Clinical Models [C] . Uwe Reusch, Stefan Knackmuss, Kristina Ellwanger, PEGS . 2014

机译：CD19 / CD3双特异性TANDAB，AFM11，在临床前模型中促进T细胞才能效果，安全地杀死CD19 +肿瘤细胞
5. Kinase Targeting Therapies in Chronic Lymphocytic Leukemia: Mechanisms of Acquired Ibrutinib Resistance and the Pre-Clinical Development of OSU-T315. [D] . Liu, Ta-Ming. 2014

机译：激酶靶向疗法在慢性淋巴细胞性白血病中：获得性依鲁替尼耐药性的机制和OSU-T315的临床前开发。
6. A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era [O] . Hannah R. Robinson, Junpeng Qi, Erika M. Cook, -1

机译：CD19 / CD3双特异性抗体可有效治疗依鲁替尼时代的慢性淋巴细胞性白血病
7. Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies [O] . H Bohlen, T Hopff, O Manzke, 1993

机译：通过用CD3 X CD19双特异性抗体激活B-慢性淋巴细胞白血病患者来自B-慢性淋巴细胞白血病患者的恶性B细胞的裂解，与二价CD28抗体组合

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era

著录项

引文网络

相似文献

相关主题

期刊订阅